Global Anti-malarial Medicines Market 2018-2022
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
Technavio’s analysts forecast the Global Anti-malarial Medicines Market to grow at a CAGR of 4.76% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the anti-malarial medicines market. To calculate the market size, the report considers the revenue generated by sales of anti-malarial drugs across the globe.
The market is divided into the following segments based on geography:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook